Sign up by using the form below and stay up to date with the latest developments in the European pharmaceutical and life sciences industry.
If you want to change your preferences just fill in this form again using the same email address or click the update preferences or unsubscribe links in any of the emails we send.
Latest content
- AbbVie’s Rinvoq approved by European Commission for non-segmental vitiligo
- Pfizer announces phase 3 results for nonsegmental vitiligo treatment
- Inizio launches Connected Insights
- Cases of skin cancer set to reach 263,000 in 2035 according to new report
- Former Serviceplan Health Managing Partner launches new consultancy
Latest intelligence
- The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
- Launching into an AI-powered future: a prescription for success
- ASCO 2026: the art of translation
- Steering generative AI into the pharma fast lane
- Bridging the gap between European brain innovation and real-world policy




